PFA
ONCY

Paradigm Financial Advisors’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Paradigm Financial Advisors’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-9,558
Closed -$17K – 256
2014
Q1 		$17K Hold
9,558
– – 0.02% 178
2013
Q4 		$15K Buy
+9,558
New +$21.5K 0.01% 204

Other funds holding ONCY

1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $62.7B AUM 37.65% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Paradigm Financial Advisors's ONCY Position: Q2 2014 in Review

Paradigm Financial Advisors sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q2 2014, closing a stake of 9,558 shares — an estimated $17K sold.

Paradigm Financial Advisors first reported a position in ONCY in Q4 2013 and held it in 2 quarters. The position peaked at $17K in Q1 2014. 34 funds tracked by Wall St. Rank hold ONCY as of Q2 2014.

  • Paradigm Financial Advisors reported no remaining ONCOLYTICS BIOTECH INC position as of Q2 2014 after selling out during the quarter.
  • Paradigm Financial Advisors sold 9,558 ONCOLYTICS BIOTECH INC shares in Q2 2014, an estimated $17K.
  • Paradigm Financial Advisors first reported a position in ONCOLYTICS BIOTECH INC in Q4 2013 and held it in 2 quarters.
  • Paradigm Financial Advisors's ONCOLYTICS BIOTECH INC position peaked at $17K in Q1 2014.
  • 34 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q2 2014.

Based on Paradigm Financial Advisors's 13F filing for Q2 2014, filed 28 Jul 2014.